Xing Xiaoping

[Expert Profile] Xing Xiaoping, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in endocrinology and bone metabolism diseases in China, working in the Department of Endocrinology, Peking Union Medical College Hospital. She has long been dedicated to clinical diagnosis, treatment, and scientific research of pseudohypoparathyroidism, calcium-phosphorus metabolism disorders, and other endocrine diseases, and is an important expert in endocrinology in China.

[Education & Career] Professor Xing Xiaoping graduated from Peking Union Medical College, completed systematic clinical training in the Department of Endocrinology at PUMCH, and further studied at famous international endocrinology centers. She has long been engaged in clinical and research work in the Department of Endocrinology at PUMCH, holding academic positions including Chair of the Osteoporosis and Bone Mineral Diseases Branch of the Chinese Medical Association. She has presided over grants from the National Natural Science Foundation of China and other projects, accumulating extensive experience in the fields of calcium-phosphorus metabolism and bone metabolism diseases.

[Areas of Expertise] Professor Xing specializes in the diagnosis and treatment of calcium-phosphorus metabolism and bone metabolism diseases such as pseudohypoparathyroidism, parathyroid dysfunction, osteoporosis, and vitamin D metabolism disorders. She has extensive experience in precise diagnosis of calcium-phosphorus metabolism disorders, standardized osteoporosis prevention and treatment, and rational application of drugs such as bisphosphonates and denosumab. She excels at managing difficult cases of "tetany, bone pain, and abnormal blood calcium," helping numerous patients correct metabolic disorders and prevent fractures.

[Academic Achievements & Industry Contributions] Professor Xing has led a series of clinical studies on osteoporosis and calcium-phosphorus metabolism diseases, systematically evaluating the epidemiological characteristics and prevention/treatment strategies of osteoporosis and metabolic bone diseases in Chinese populations, with findings published in authoritative domestic and international journals. She has led the development of Chinese osteoporosis and calcium-phosphorus metabolism disease diagnosis and treatment guidelines and expert consensus statements, actively promoted the popularization of standardized osteoporosis prevention and treatment and bone density screening, and organized national bone metabolism disease specialty training, making important contributions to improving the prevention and treatment level of osteoporosis and calcium-phosphorus metabolism diseases in China.

[Clinical Practice & Outstanding Contributions] Professor Xing has long held expert endocrinology clinics, cumulatively treating tens of thousands of patients with osteoporosis and various endocrine diseases, developing standardized treatment plans for countless patients with "recurrent fractures and bone pain." She is gentle and patient with patients, and is deeply trusted by patients. She has repeatedly organized osteoporosis science popularization and free clinics, actively advocated for the concept that "bone health starts with early prevention," and is a widely respected expert in the fields of endocrinology and bone metabolism.

[Honors & Reputation] Professor Xing Xiaoping serves as Deputy Director of the Department of Endocrinology at Peking Union Medical College Hospital and Chair of the Osteoporosis and Bone Mineral Diseases Branch of the Chinese Medical Association, among other academic positions. She has presided over national-level projects including grants from the National Natural Science Foundation of China, and is a senior expert in the fields of endocrinology and bone metabolism diseases in China. She has profound expertise in the diagnosis and treatment of pseudohypoparathyroidism and difficult calcium-phosphorus metabolism diseases. She has led research on standardized osteoporosis prevention and treatment and bone density screening, promoted the construction of China's osteoporosis prevention and treatment system, and participated in the development of multiple osteoporosis diagnosis and treatment guidelines. For decades on the clinical front lines, she has helped numerous osteoporosis patients prevent fractures and improve bone health, and is deeply trusted by patients and respected by peers alike.